162 related articles for article (PubMed ID: 10494453)
1. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats.
Yamada S; Harano M; Annoh N; Nakamura K; Tanaka M
Biol Psychiatry; 1999 Sep; 46(6):832-8. PubMed ID: 10494453
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.
Semenova S; Geyer MA; Sutcliffe JG; Markou A; Hedlund PB
Biol Psychiatry; 2008 Jan; 63(1):98-105. PubMed ID: 17531208
[TBL] [Abstract][Full Text] [Related]
3. Nicotine blocks apomorphine-induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic alpha7 receptors.
Suemaru K; Yasuda K; Umeda K; Araki H; Shibata K; Choshi T; Hibino S; Gomita Y
Br J Pharmacol; 2004 Jul; 142(5):843-50. PubMed ID: 15197106
[TBL] [Abstract][Full Text] [Related]
4. Effects of sigma(1) receptor ligand, MS-377 on apomorphine- or phencyclidine-induced disruption of prepulse inhibition of acoustic startle in rats.
Yamada S; Yamauchi K; Hisatomi S; Annoh N; Tanaka M
Eur J Pharmacol; 2000 Aug; 402(3):251-4. PubMed ID: 10958892
[TBL] [Abstract][Full Text] [Related]
5. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle.
Keith VA; Mansbach RS; Geyer MA
Biol Psychiatry; 1991 Sep; 30(6):557-66. PubMed ID: 1834231
[TBL] [Abstract][Full Text] [Related]
6. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.
Linn GS; Negi SS; Gerum SV; Javitt DC
Psychopharmacology (Berl); 2003 Sep; 169(3-4):234-9. PubMed ID: 12845408
[TBL] [Abstract][Full Text] [Related]
7. [Disruption of prepulse inhibition of acoustic startle as an animal model for schizophrenia].
Yamada S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):131-9. PubMed ID: 11215397
[TBL] [Abstract][Full Text] [Related]
8. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
9. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
[TBL] [Abstract][Full Text] [Related]
10. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat.
Johansson C; Jackson DM; Svensson L
Psychopharmacology (Berl); 1994 Dec; 116(4):437-42. PubMed ID: 7701046
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of the strychnine-insensitive glycine site antagonist (+)-HA-966 on the hyperactivity and the disruption of prepulse inhibition induced by phencyclidine in rats.
Furuya Y; Kagaya T; Nishizawa Y; Ogura H
Brain Res; 1998 Jan; 781(1-2):227-35. PubMed ID: 9507144
[TBL] [Abstract][Full Text] [Related]
12. The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice.
Fejgin K; Safonov S; Pålsson E; Wass C; Engel JA; Svensson L; Klamer D
Psychopharmacology (Berl); 2007 Apr; 191(2):377-85. PubMed ID: 17235612
[TBL] [Abstract][Full Text] [Related]
13. Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia.
Elmer GI; Sydnor J; Guard H; Hercher E; Vogel MW
Psychopharmacology (Berl); 2004 Jul; 174(2):177-89. PubMed ID: 14985933
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.
Oliveras I; Sánchez-González A; Sampedro-Viana D; Piludu MA; Río-Alamos C; Giorgi O; Corda MG; Aznar S; González-Maeso J; Gerbolés C; Blázquez G; Cañete T; Tobeña A; Fernández-Teruel A
Psychopharmacology (Berl); 2017 Mar; 234(6):957-975. PubMed ID: 28154892
[TBL] [Abstract][Full Text] [Related]
15. "Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits.
Martinez ZA; Oostwegel J; Geyer MA; Ellison GD; Swerdlow NR
Neuropsychopharmacology; 2000 Nov; 23(5):517-27. PubMed ID: 11027917
[TBL] [Abstract][Full Text] [Related]
16. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
Gogos A; Kwek P; Chavez C; van den Buuse M
J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
[TBL] [Abstract][Full Text] [Related]
17. The adenosine A2A agonist CGS 21680 reverses the reduction in prepulse inhibition of the acoustic startle response induced by phencyclidine, but not by apomorphine and amphetamine.
Sills TL; Azampanah A; Fletcher PJ
Psychopharmacology (Berl); 2001 Jul; 156(2-3):187-93. PubMed ID: 11549222
[TBL] [Abstract][Full Text] [Related]
18. The Effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice.
Yee BK; Chang DL; Feldon J
Neuropsychopharmacology; 2004 Oct; 29(10):1865-77. PubMed ID: 15127085
[TBL] [Abstract][Full Text] [Related]
19. Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats.
Wadenberg MG; Sills TL; Fletcher PJ; Kapur S
Biol Psychiatry; 2000 Apr; 47(7):670-6. PubMed ID: 10745061
[TBL] [Abstract][Full Text] [Related]
20. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity.
Kinney GG; Wilkinson LO; Saywell KL; Tricklebank MD
J Neurosci; 1999 Jul; 19(13):5644-53. PubMed ID: 10377370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
